re: Ann: Patrys to Initiate Clinical Trial wi... Mrs, PAB are working on many antibodies to try and cure many types if cancer. SM6 is just one of the two most advanced. It has shown benefit in Myeloma and been trialled for Melanoma. At this stage concentrating on the former.
- Forums
- ASX - By Stock
- PAB
- Ann: Patrys to Initiate Clinical Trial with Onyx
Ann: Patrys to Initiate Clinical Trial with Onyx , page-19
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $5.431K | 1.357M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 26519870 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 7889760 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 26519870 | 0.004 |
30 | 26629632 | 0.003 |
16 | 21570001 | 0.002 |
11 | 48751998 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 7889760 | 12 |
0.006 | 9510918 | 10 |
0.007 | 1525381 | 3 |
0.008 | 75000 | 1 |
0.010 | 46000 | 1 |
Last trade - 11.23am 15/11/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online